Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.32 USD | -0.94% | +8.22% | +25.15% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.15% | 774M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-3.14% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Wave Life Sciences : Mizuho Securities Adjusts Price Target on WAVE Life Sciences to $19 From $21, Reiterates Buy Rating